Clinical trial
A Phase I Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease
NCT03068481 is registered in ClinicalTrials.gov with Kissei Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease
- Lead sponsor
- Kissei Pharmaceutical Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 20, 2017
- Completion date
- August 13, 2018
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.